Fungi evolved over a billion years ago - long before plants - reshaping the timeline of early life and Earth’s first ...
“Our work is the first to directly test how chromosome structure affects bacterial growth, survival, and ability to cause ...
The 2022 Option Agreement between Astellas and Taysha has expiredRegaining full rights to TSHA-102 Rett syndrome program enables Taysha to focus ...
Taysha Gene Therapies shares fall after regaining full rights to Rett syndrome drug TSHA-102 and finalizing FDA alignment for ...
Rapid advances in viral vectors, advanced plasmid DNA and oncology drive new expansion in global markets.Austin, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Gene Therapy Starting Materials Market Size & Growth ...
Cedar Rapids KCRG-TV on MSN
Iowa State University research untangles chromosomes in building block of GMO crops
Iowa State University researchers have unlocked new secrets within the bacteria responsible for the creation of thousands of ...
Nanoplastics, according to one study, can damage DNA, disrupt cell functions, and cause chronic inflammation. These materials ...
Researchers in Japan have genetically transferred a unique courtship behavior from one fruit fly species to another. By turning on a single gene in insulin-producing neurons, the team successfully ...
Gene tree and species tree reconciliation is a pivotal framework in evolutionary biology that bridges the evolutionary histories of individual gene families with the broader context of species ...
US-based Cibus Inc will provide its gene editing technologies in partnership with industry and government stakeholders in ...
In the latest quarter, 6 analysts provided ratings for Taysha Gene Therapies (NASDAQ:TSHA), showcasing a mix of bullish and bearish perspectives. The table below offers a condensed view of their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback